Aldeyra Therapeutics, Inc.

This study tested a new drug called ADX-629 to see if it is safe and helpful for adults with moderate alcohol hepatitis, a serious liver inflammation. It was a small, early-stage trial with just 4 participants. The main goal was to check for side effects while participants agreed…

This study tested whether a new eye drop called reproxalap could safely reduce the discomfort of dry eye disease. Over 400 adults with dry eye symptoms used either the active eye drops or a placebo (vehicle) solution for six weeks. The main goal was to see if the drops lowered pa…

This completed Phase 3 trial tested whether reproxalap eye drops could reduce discomfort in people with dry eye disease. The study compared the active drops against placebo drops in 116 participants. Researchers measured eye discomfort using a special dry eye chamber to see if th…

This study tested the safety of a new eye drop called reproxalap for people with dry eye disease. Over 750 participants used the eye drop or a placebo (inactive) drop for up to a year. The main goal was to check for serious side effects related to vision, eye pressure, and the he…